Table 1.
Variables | Oropharyngeal (n=555) |
Non-Oropharyngeal (n=579) |
Total Sample (N=1151) |
---|---|---|---|
| |||
n (%)/M (SD) | n (%)/M (SD) | N (%)/M (SD) | |
Neighborhood deprivation** | |||
Low to Moderate | 451 (81.3) | 406 (70.1) | 863 (75.0%) |
High | 104 (18.7) | 173 (29.9) | 288 (25.0%) |
Cancer stage** | |||
Stage I/II | 47 (8.5) | 232 (40.1) | 283 (24.6%) |
Stage III/IV | 508 (91.5) | 347 (59.9) | 868 (75.4%) |
Cancer Treatment** | |||
Single Modality | 188 (33.9) | 256 (44.2) | 447 (38.8%) |
Multiple Modalities | 367 (66.1) | 323 (55.8) | 704 (61.2%) |
Sex** | |||
Female | 82 (14.8) | 174 (30.1) | 260 (22.6%) |
Male | 473 (85.2) | 405 (69.9) | 891 (77.4%) |
Race/Ethnicity** | |||
Other | 65 (11.7) | 141 (24.4) | 211 (18.3%) |
Non-Hispanic White | 490 (88.3) | 438 (75.6) | 940 (81.7%) |
Smoking status** | |||
Current/Former | 342 (61.6) | 464 (80.1) | 821 (71.3%) |
Never | 213 (38.4) | 115 (19.9) | 330 (28.7%) |
Annual household income** | |||
<$25,000 | 75 (14.0) | 185 (32.6) | 265 (23.7%) |
$25,000-74,900 | 182 (34.0) | 250 (44.1) | 439 (39.2%) |
≥$75,000 | 278 (52.0) | 132 (23.3) | 415 (37.1%) |
Age** | 55.7 (9.1) | 59.5 (12.0) | 57.7 (10.8) |
Overall Death Event** | |||
No | 447 (80.5) | 415 (71.7) | 870 (75.6%) |
Yes | 108 (19.5) | 164 (28.3) | 281 (24.4%) |
Disease-specific Death Event* | |||
No | 489 (88.1) | 484 (83.6) | 984 (85.5%) |
Yes | 66 (11.9) | 95 (16.4) | 167 (14.5%) |
Cancer Recurrence Event | |||
No | 463 (83.4) | 457 (78.9) | 933 (81.1%) |
Yes | 92 (16.6) | 122 (21.1) | 218 (18.9%) |
Second Primary Malignancy Event | |||
No | 517 (93.2) | 534 (92.2) | 1054 (91.6%) |
Yes | 38 (6.8) | 45 (7.8) | 97 (8.4%) |
Note: p< 0.05
p< 0.001: M=mean, SD=standard deviation.